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A B S T R A C T
The aim of the study was to analyze the evidence-based use of antibiotic therapy in the treatment of acute pancreatitis
and to identify factors influencing the introduction of antibiotic therapy in the setting of transitional country clinical
hospital. This retrospective study was conducted at Department of Internal Medicine at University Hospital Dubrava in
Zagreb, Croatia. Data were collected from hospital records of patients treated for acute pancreatitis from January 1st,
2005 till December 31st, 2005. Data collected from patients’ histories were compared with indications for antibiotic treat-
ment and antibiotics with demonstrated therapeutic efficacy in acute pancreatitis which were obtained from published
literature. Logistic regression was used to identify factors with a significant impact on deciding on the introduction of
antibiotic therapy, and multivariate analysis was used to identify factors with a significant impact on the cost of treat-
ment. Statistical significance was set at p<0.05. Antibiotic therapy was used in 67.7% of patients with acute pancreatitis.
Combination of amoxicillin plus clavulanic acid was most frequently administered, either as monotherapy or in combi-
nation with metronidazole and/or gentamicin (37.3%), followed by cefuroxime (32.8%) and cefoperazone (26.9%). The
choice of antibiotic was appropriate in 35.8% of study patients; however in 29.9% of patients who were administered anti-
biotics had no indication for this therapy; and 46.9% of patients who had indications for receiving antibiotic therapy didn’t
receive it. In the groups of patients treated with antibiotics, the cost of treatment was significantly higher compared to
groups of patients who were not treated with antibiotics (p=0.0035; p=0.0026). In addition to antibiotic therapy, the cost
of treatment was significantly influenced by the length of hospital stay and treatment at intensive care unit. The use of
antibiotics in the setting of transitional country university hospital in patients with acute pancreatitis is not evidence-
-based. Decision on the introduction of antibiotic therapy is not based on objective parameters of disease severity or evi-
dence of therapeutic efficacy of particular antibiotics. The cost of treatment is significantly increased by the use of antibi-
otic therapy.
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Introduction
Acute pancreatitis is a common disease with an in-
creasing prevalence worldwide. It is estimated that 210,000
patients are hospitalized for acute pancreatitis per year
in USA1. In Great Britain, the incidence of acute pancre-
atitis was 21 per million in the mid-1970s, increasing to
242 permillion by the mid-1980s. The cause of this grow-
ing tendency has not been fully clarified; however, it has
been postulated to be due to the increasing alcohol intake
and improved disease diagnosis2.
In most cases, acute pancreatitis is a mild disease
with a mortality rate less than 1%. However, 20% of pa-
tients develop a severe form of the disease with pancre-
atic necrosis. Infection of the pancreas as a major cause
of mortality and morbidity occurs in 40–70% of patients
with acute necrotizing pancreatitis. In these patients,
mortality rises to 10% and 25–40% in case of sterile and
infected pancreatic necrosis, respectively1,3. Therefore,
attempts to prevent infection and reduce mortality in pa-
tients with necrotizing pancreatitis are quite reasonable.
The earliest studies published some 30 years ago regard-
ing antibiotic prophylaxis in acute pancreatitis failed to
demonstrate favourable effects of ampicillin on the course
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of acute pancreatitis4. In 1993, Pederzoli et al. published
results of a randomized clinical trial demonstrating im-
ipenem to significantly reduce the incidence of septic
complications in patients with acute pancreatitis, but
with no effect on mortality5. Similar results have been
reported by Røkke et al. in 20076. Pancreatic concentra-
tion of imipenem is bactericidal for most bacteria causing
infectious complications2. In 2003, Manes et al. reported
results of a randomized clinical trial demonstrating me-
ropenem to be as efficacious as imipenem in patients
with pancreatic necrosis7.
Because of their favourable pharmacokinetic profile,
fluoroquinolones have been postulated to be effective in
preventing infection in severe acute pancreatitis. In a
controlled randomized clinical trial, pefloxacin proved to
be less efficacious than imipenem in patients with acute
necrotizing pancreatitis8. Results of a randomized dou-
ble-blind clinical trial comparing a combination of cipro-
floxacin and metronidazole with placebo in patients with
necrotizing pancreatitis were published in 2004. There
was no significant difference in the incidence of necrotic
pancreatic tissue infection, morbidity and mortality9.
»Sainio et al. reported results of their randomized clini-
cal trial demonstrating cefuroxime to significantly re-
duce mortality in patients with necrotizing pancreatitis
of alcohol aetiology as compared with placebo. Cefuro-
xime was chosen because the most common causes of
sepsis were sensitive to it 10«.
According to the published therapeutic guidelines,
the use of imipenem or cefuroxime is most commonly
recommended for the treatment of patients with acute
pancreatitis11–15.
Antibiotic prophylaxis is not indicated in all patients
with acute pancreatitis. First meta-analyses of prospec-
tive studies on the prophylactic effect of antibiotics on
the course of acute pancreatitis suggest that antibiotic
prophylaxis can reduce mortality and morbidity only in
patients with severe form of the disease. This refers to
patients with score 3 according to Ranson-Imrie criteria
for assessment of the acute pancreatitis severity or with
pancreatic necrosis verified by computed tomography
(CT)4,15. According to the results of the most recent
meta-analysis the use of prophylactic antibiotics is se-
verely challenged and the authors claim that antibiotics
cannot reduce infected pancreatic necrosis and mortality
in patients with acute necrotizing pancreatitis17. Never-
theless, majority of therapeutic guidelines recommend
antibiotic prophylaxis in patients with severe acute pan-
creatitis10–14. The risk of developing acute necrotizing
pancreatitis can be assessed according to plasma concen-
tration of C-reactive protein (CRP). The risk is low and
antibiotic prophylaxis is not justified in patients with
plasma CRP concentration lower than 110 mg/L18. In our
country Croatia, which is still undergoing the process of
transition there are no formal guidelines regarding the
management of acute pancreatitis.
The aim of our study was to assess the rate of evi-
dence-based usage of antibiotics in acute pancreatitis
and to identify the factors that influence decision on the
introduction of antibiotic therapy in the setting of transi-
tional country university hospital.
Methods
This retrospective study was conducted at Depart-
ment of Internal Medicine, University Hospital Dubrava
in Zagreb, Croatia. Data were collected from hospital re-
cords on patients of both genders treated for acute pan-
creatitis from January 1st 2005 till December 31st 2005.
Establishing the diagnosis of acute pancreatitis was
defined by two criteria that had to be met: presence of
abdominal pain; and serum amylase concentration in-
creased at least threefold normal values.
Patients with other conditions requiring antibiotic
therapy such as acute cholecystitis, cholangitis, pneumo-
nia, urinary tract infection were not included. Data on
patient age and gender, pancreatitis aetiology, length of
hospital stay, cost of treatment, CRP concentration and
disease outcome were collected for all study patients.
Disease severity was evaluated according to Ranson-
-Imrie criteria on admission and 48h of admission to
hospital18. According to the severity of acute pancreati-
tis, patients were divided into three groups: mild (Ran-
son-Imrie criteria score <3), moderate (Ranson-Imrie
criteria score 3 to 5) and severe (Ranson-Imrie criteria
score >5).
During hospital stay, all patients underwent ultraso-
nography of the abdomen. When ultrasonography of the
abdomen or clinical course of the disease raised suspicion
of pancreatic necrosis, CT of the abdomen was obtained in
order to confirm the diagnosis of necrotizing pancreatitis.
Data on antibiotics received during inpatient treat-
ment were collected for all study patients.
Indications for the use of antibiotics were determined
from literature data4,14–16. Antibiotics were considered to
be indicated if at least one of the following criteria was
met: pancreatic necrosis verified by CT of the abdomen,
Ranson-Imrie criteria score 3 and plasma CRP concen-
tration >110 mg/L.
According to literature data, imipenem, meropenem
and cefuroxime were considered the antibiotics of choi-
ce5–7,12–15.
Study patients were classified into four groups ac-
cording to the presence of indications for antibiotic ther-
apy and use of antibiotic therapy. The cost of treatment
was compared between the groups of patients with indi-
cations for antibiotic therapy who were and were not ad-
ministered antibiotics. The cost of treatment was also
compared between the groups of patients without indica-
tions for antibiotic therapy who were and were not ad-
ministered antibiotics.
Statistical analysis: Mann-Withney U test was used to
compare continuous variables and c2 analysis (or Fisher
exact test) was used to analyze differences between cate-
gorical variables. Logistic regression was used to deter-
mine relative importance of factors with impact on the
decision to introduce antibiotic therapy, while multi-
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varate analyses of associations with the cost of treatment
were assesed using multiple regression. Statistical signif-
icance was inferred at p<0.05. The variables that did not
follow normal distribution were logarithmized for logis-
tic regression and multivariate analysis. Statistical anal-
yses were done using Statistica for Windows, Version 5.5.
Results
The study included 99 patients. Data on patient age
and gender, disease aetiology, length and cost of hospital
stay, parameters of disease severity and disease outcome
are shown in Table 1.
Out of 99 study patients, 67.7% were administered
antibiotic therapy. Amoxicillin plus clavulanic acid was
most frequently used, either as monotherapy or in com-
bination with metronidazole and/or gentamicin, being
received by 37.3% of study patients. Cefuroxime was ad-
ministered as monotherapy or in combination with me-
tronidazole and/or gentamicin in 32.8%, cefoperazone in
26.9%, and a carbapenem as monotherapy or in combina-
tion with metronidazole and/or gentamicin in 3% of
study patients. Appropriate choice of antibiotics was re-
corded in 35.8% of patients.
Antibiotics were administered in 75% of patients with
acute pancreatitis caused by gallstones or secondary to
endoscopic retrograde cholangiopancreatography (ERCP).
In this group, the leading antibiotic was cefoperazone
(33.3%), followed by amoxicillin plus clavulanic acid and
cefuroxime (31% each), and imipenem (4.7%) adminis-
tered as monotherapy or in combination with metroni-
dazole and/or gentamicin.
Antibiotics were received by 59% of patients with
acute pancreatitis caused by excessive alcohol consump-
tion. In this group, the leading antibiotic was amoxicillin
plus clavulanic acid (50%), followed by cefuroxime (43.7%)
and cefoperazone (6.3%) as monotherapy or in combina-
tion with metronidazole and/or gentamicin.
Antibiotic therapy was used in 56.3% of the remain-
ing 16 patients. The leading antibiotic was amoxicillin
with clavulanic acid (44.4%), followed by cefoperazone
(33.3%) and cefuroxime (22.2%) as monotherapy or in
combination with metronidazole and/or gentamicin (Ta-
ble 2).
Indications for the use of antibiotics were present in
70.1% and absent in 29.9% of 67 patients administered
antibiotic therapy. Indications for the use of antibiotics
were present in 46.9% and absent in 53.1% of 32 patients
that were not administered antibiotic therapy.
Logistic regression identified indication for CT of the
abdomen as the only parameter showing a statistically
significant correlation with the decision on antibiotic
therapy introduction (Table 3). Comparison of patient
groups with indications for antibiotic therapy showed
the cost of treatment to be statistically significantly
higher in the group of patients administered antibiotic
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TABLE 1
DEMOGRAPHIC AND CLINICAL DATA OF STUDY PATIENTS
– PATIENTS TREATED FOR ACUTE PANCREATITIS FROM
JANUARY 1ST 2005 TILL DECEMBER 31ST 2005, DEPARTMENT
OF INTERNAL MEDICINE, UNIVERSITY HOSPITAL DUBRAVA,
ZAGREB, CROATIA
Number of patients 99
Gender
Male
Female
59 (59.6%)
40 (40.4%)
Age, yrs (median, minimum-maximum) 61 (22–89)
Aetiology
Gallstones
Alcohol
Alcohol + gallstones
Triglycerides
Post-ERCP
Idiopathic
54 (54.5%)
27 (27.3%)
4 (4.0%)
2 (2.0%)
2 (2.0%)
10 (10.1%)
Length of hospital stay, days (median,
minimum-maximum)
11 (1–32)
Cost, EUR (median, minimum-maximum) 963 (187–4938)
Severity, Ranson-Imrie criteria
Mild (0–2)
Moderate (3–5)
Severe (6–9)
45 (45.5%)
47 (47.5%)
7 (7.0%)
CRP, mg/L (median, minimum-maximum) 68.7 (0.6–422)
Death 6 (6.1%)
TABLE 2
CHOICE OF ANTIBIOTICS ACCORDING TO DISEASE AETIOLOGY – PATIENTS TREATED FOR ACUTE PANCREATITIS FROM JANUARY
1ST 2005 TILL DECEMBER 31ST 2005, DEPARTMENT OF INTERNAL MEDICINE, UNIVERSITY HOSPITAL DUBRAVA, ZAGREB, CROATIA
Antibiotic
Number of
patients (n=67)
Choice of antibiotic according to disease aetiology
Alcohol
(n=16)
Gallstones +
post-ERCP (n=42)
Other
(n= 9)
Amoxicillin plus clavulanic acid* 37.3% (n=25) 50% (n=8) 31% (n=13) 44.4% (n=4)
Cefuroxime* 32.8% (n=22) 43.7% (n=7) 31% (n=13) 22.2% (n=2)
Cefoperazone* 26.9% (n=18) 6.3% (n=1) 33.3% (n=14) 33.3% (n=3)
Carbapenems (imipenem or meropenem)* 3% (n=2) 0% 4.7% (n=2) 0%
* monotherapy or combination with metronidazole and/or gentamicin
therapy than in those that did not receive it (Figure 1).
Pancreatic necrosis was verified by CT of the abdomen in
six patients from the group administered antibiotic ther-
apy and none from the group without antibiotic therapy.
As a severe course of the disease associated with a signifi-
cant increase in the cost of treatment can be expected in
patients with pancreatic necrosis verified by CT of the
abdomen, these patients were excluded from comparison
studies.
Comparison of patient groups without indications for
antibiotic therapy showed the cost of treatment to be sta-
tistically significantly higher in the group of patients ad-
ministered antibiotic therapy than in those that did not
receive it (Figure 2).
Multivariate analysis identified the length of hospital
stay, treatment at intensive care unit (ICU) and use of
antibiotics as the parameters that statistically signifi-
cantly influenced the cost of treatment (Table 4).
The length of hospital stay was longer and the propor-
tion of patients treated at ICU greater in the groups of
patients administered antibiotic therapy as compared
with the groups of patients without antibiotic therapy,
however, the difference did not reach statistical signifi-
cance. Six patients died, all of them with indications for
antibiotic therapy. Five of these six patients were admin-
istered antibiotics, whereas one patient did not receive
antibiotic therapy. Mortality difference was not statisti-
cally significant.
Discussion
Study results showed that the majority of study pa-
tients (67.7%) were administered antibiotic therapy. Yet,
an appropriate choice of antibiotics was recorded in only
35.8% of patients, whereas the rest of patients were ad-
ministered antibiotics without evidence of therapeutic
efficacy in acute pancreatitis.
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TABLE 3
LOGISTIC REGRESSION FOR THE USE OF ANTIBIOTICS
– PATIENTS TREATED FOR ACUTE PANCREATITIS FROM
JANUARY 1ST 2005 TILL DECEMBER 31ST 2005, DEPARTMENT
OF INTERNAL MEDICINE, UNIVERSITY HOSPITAL DUBRAVA,
ZAGREB, CROATIA
OR (95%CI) p
Gender 0.347 (0.11–1.091) n.s.
Age 1.009 (0.971–1.048) n.s.
Biliary aetiology +
post-ERCP
2.16 (0.90–5.14) n.s.
Alcohol etiology 0.60 (0.236–1.521) n.s.
Ranson-Imrie criteria 1.188 (0.70–2.016) n.s.
Leukocytosis >16000/mL 0.969 (0.211–4.441) n.s.
Necrosis on
ultrasonography
2.373 (0.206–27.39) n.s.
Indication for CT scan 5.36 (1.45–19.83) 0.012
Treatment at ICU 2.445 (0.502–11.910) n.s.
Serum CRP 1.147 (0.85–1.547) n.s.
Serum amylases 1.00 (0.999–1.001) n.s.
Serum LDH >400 IU/L 0.603 (0.148–2.46) n.s.
n.s. – not significant
TABLE 4
MULTIVARIATE MODEL FOR TREATMENT COST – PATIENTS
TREATED FOR ACUTE PANCREATITIS FROM JANUARY 1ST 2005
TILL DECEMBER 31ST 2005, DEPARTMENT OF INTERNAL MEDI-
CINE, UNIVERSITY HOSPITAL DUBRAVA, ZAGREB, CROATIA
Regression
coefficient
P
Hospital stay, days 100 <0.0001
Treatment at ICU 754 <0.0001
Antibiotic therapy 275 <0.008
CT scan 122 n.s.
Necrosis on US 153 n.s.
Ranson-Imrie criteria 18 n.s.
Age –1.5 n.s.
Multiple r = 0.90; F = 37.526; p<0.0001
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Fig. 1. Cost of treatment in patient groups with indications for
antibiotic therapy.
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Fig. 2. Cost of treatment in patient groups without indications
for antibiotic therapy.
Most patients (37.3%) received a combination of amo-
xicillin and clavulanic acid. This antibiotic has for years
been the most widely prescribed and unjustifiably over-
used antibiotic in Croatia, mainly due to intensive mar-
keting factors and long-standing presence of the drug on
the market. This has entailed prescribing of the antibi-
otic out of custom, also for indications that lack any evi-
dence for its efficacy and in conditions that may require
antibiotics of a considerably narrower antimicrobial spe-
ctrum.
Cefuroxime was the second leading antibiotic, admin-
istered in 32.8% of study patients. As cefuroxime is much
less expensive than carbapenems and there is evidence
for its therapeutic efficacy, it could be considered optimal
antibiotic for the treatment of patients with acute pan-
creatitis in our circumstances. However, it should be pre-
ceded by comprehensive information on the most com-
mon agents causing infection in patients with acute
pancreatitis and their sensitivity to cefuroxime.
The next most common antibiotic was cefoperazone,
received by 26.9% of study patients. This antibiotic was
most frequently used in patients with acute pancreatitis
due to gallstones or secondary to ERCP. As cefoperazone
is mostly excreted via biliary tract, in our hospital it has
mostly been used in the management of patients with
biliary tract infection. However, there is no evidence for
therapeutic efficacy of cefoperazone in this indication to
be superior to therapeutic efficacy of other, less toxic and
less expensive beta-lactam antibiotics such as cefotaxime
and ceftriaxone19–22. Such a high utilization of cefopera-
zone is not justified, the more so as patients with clinical,
radiographic or laboratory signs of biliary tract infection
were not included in the study.
Only 3% of study patients were administered a carba-
penem (imipenem or meropenem). While the percentage
of these patients was definitely too low, the use of this
group of antibiotics is not likely to be justified in all pa-
tients with indications for antibiotic prophylaxis because
of the high price of carbapenems and the potential risk of
bacterial resistance induction.
Interestingly enough, none of the study patients re-
ceived ciprofloxacin. At our hospital, the utilization of
this antibiotic has increased by 160% in the past five
years, which will certainly have unfavourable effect on
bacterial resistance (unpublished results).
A high proportion of study patients (29.9%) were ad-
ministered antibiotics without strict indications. Such
inappropriate use of antibiotics is associated with the un-
necessary risk of side effects, superinfection, induction of
bacterial resistance, and increased cost of treatment4,13,15.
The use of antibiotics without strict indications resulted
in unnecessary expenses of about 8460 EUR, i.e. an
amount that would cover treatment cost for 15 patients
with a mild form of acute pancreatitis requiring no anti-
biotic therapy, or for 7 patients with a severe form of
acute pancreatitis requiring antibiotic therapy. In con-
trast, 46.9% of patients from the group without antibi-
otic therapy had indications for antibiotic prophylaxis.
Although a more severe course of the disease could be ex-
pected in this group of patients, there was no statistically
significant mortality difference from the group of pa-
tients administered antibiotic therapy.
Study results revealed the lack of any objective pa-
rameters on making indications for antibiotic therapy.
Logistic regression identified the indication for CT of the
abdomen as the only parameter showing statistically sig-
nificant correlation with the introduction of antibiotic
therapy. Antibiotic therapy appears to be initiated exclu-
sively on the basis of clinician’s subjective assessment of
the disease severity, thus influencing further diagnostic
work-up.
Comparison of patient groups according to the cost of
treatment revealed it to be statistically significantly
higher in the groups administered antibiotics than in
those without this therapy. It is generally believed that
CT scanning significantly increases the cost of treat-
ment; however, it was not confirmed in the present study.
Conclusion
In conclusion, the use of antibiotics in observed popu-
lation of acute pancreatitis patients in University Hospi-
tal Dubrava is not evidence-based. Neither parameters of
the disease severity nor evidence for therapeutic efficacy
of particular antibiotics are considered on making indica-
tions for the introduction of antibiotic therapy. There-
fore, antibiotic prophylaxis is not used in a large propor-
tion of patients with proper indications, while being used
in many patients without such indications. Inappropri-
ate choice of antibiotics and use of antibiotics lacking evi-
dence of therapeutic efficacy in acute pancreatitis were
recorded in most patients. The cost of treatment is signif-
icantly increased with the introduction of antibiotic ther-
apy, which is another reason to invest additional efforts
to turn to appropriate use of antibiotics, and to introduce
antibiotic prophylaxis only when indicated. The manage-
ment of patients with acute pancreatitis could be signifi-
cantly improved by the introduction of therapeutic gui-
delines strictly defining indications for antibiotic pro-
phylaxis applicable to the local settings.
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UPOTREBA ANTIBIOTIKA U LIJE^ENJU AKUTNOG PANKREATITISA
– ISKUSTVO IZ JEDNE KLINI^KE BOLNICE ZEMLJE U TRANZICIJI
S A @ E T A K
»Ciljevi ove studije uklju~uju analizu upotrebe antibiotika u lije~enju akutnog pankreatitisa u klini~koj bolnici tran-
zicijske zemlje, usporedbu s publiciranim smjernicama, uz identifikaciju ~imbenika koji utje~u na odabir i uvo|enje
antibiotskog lije~enja.« Ova retrospektivna studija provedena je na Klinici za internu medicinu Klini~ke bolnice »Du-
brava«, Zagreb, Hrvatska. Podaci su sakupljeni iz bolni~kih arhiva pacijenata koji su lije~eni radi akutnog pankreatitisa
u razdoblju od 1.1.2005. do 31.12.2005. Tako sakupljeni podaci su uspore|eni sa publiciranim smjernicama za lije~enje
akutnog pankreatitisa. Logi~ka regresija kori{tena je sa ciljem identifikacije statisti~ki zna~ajnih ~imbenika koji utje~u
na odluku o uvo|enju antibiotske terapije, a multivarijantna analiza je kori{tena sa ciljem identifikacije ~imbenika koji
imaju utjecaj na cijenu lije~enja. Statisti~ka zna~ajnost zadana je za p<0,05. Antibiotici su kori{teni u 67,7% pacijenata
koji su lije~eni radi akutnog pankreatitisa. Kombinacija amoksicilina i klavulanske kiseline je naj~e{}e propisivani anti-
biotik, samostalno ili u kombinaciji sa metronidazolom i/ili gentamicinom (37,3%), slijedi cefuroksim (32,8%) i cefo-
perazon (26,9%). Izbor antibiotika bio je ispravan u 35,8% slu~ajeva, me|utim u 29,9% slu~ajeva nije bilo indikacije za
antibiotskim lije~enjem. U skupini pacijenata koji su lije~eni antibiotikom, cijena lije~enja je bila zna~ajno vi{a u odnosu
na skupinu koja nije bila lije~ena antibiotikom (p=0,0035; p=0,0026). Cijena lje~enja je tako|er bila uvjetovana du`i-
nom intrahospitalnog boravka i lije~enjem u jedinici intenzivnog lije~enja. Upotreba antibiotika u okru`ju klini~ke
bolnice zemlje u tranziciji nije temeljena na dokazima publiciranim u literaturi. Odluka o uvo|enju antibiotika nije
temeljena na objektivnim parametrima te`ine bolesti kako ni na terapijskoj u~inkovitosti odre|enog antibiotika. Cijena
lije~enja zna~ajno je uvjetovana kori{tenjem antibiotika.
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